Editas Medicine is down a bit on the day, funds flowing out kept the price down -1.83% since yesterday.
Currently EDIT isn't at a clear support/resistance line that seems tradable. Editas Medicine hasn't shown a lot of strength recently, shareholders don't seem that energized about the Biotechnology company's future prospects. EDIT might find some support at the 7.81 level, buyers might push the price back up from here. But it's not very clear what will happen.
Overall, the analysts have a more negative view on Editas Medicine but it's not a very strong negative. The current Analysts Sentiment Score is -42.95. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. Wells Fargo & Company dropped their price target by -16.67% to $30.00 on 2023-02-23. On 2023-02-23 Credit Suisse Group increased their price target by 15.38% to $15.00. Chardan Capital decided to move down their price target on 2023-02-23 to $22.00 which is a -37.14% decrease. Royal Bank of Canada announced a lowering of their price target to $10.00 from $14.00 on 2023-02-23. Cantor Fitzgerald announced that they are initiating coverage with a rating of Overweight on 2023-01-31 and they set their price target at $15.00.Morgan Stanley announced a lowering of their price target to $7.00 from $8.00 on 2023-01-24. SVB Leerink boosted their price targ by 16.67% to $7.00 on 2023-01-23. Citigroup initiated a rating of Neutral on 2022-12-13 and provided a price target of $11.00. Evercore ISI provided a price target drop to 8.00 on 2022-11-21. Robert W. Baird provided a price target decease of -28% to $18.00 from $25.00 on 2022-11-18.
| Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
|---|---|---|---|---|---|
| EDIT | -42.95 | 58.11 | -25.13 | 110.23 | -229.12 |
| Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
|---|---|---|
| EDIT | -11.45 | 2.95 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
| Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
|---|---|---|---|---|---|
| EDIT | 23.67 | %30.9503 | 12.3 | 12.804 | 21170000 |
| Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology | 367 | 1.85 | -0.88 | -10.56 | 1.85 | -7.04 | -22.15 | 31.57 | -13.77 | -17.27 | -13.81 | -41814.93 | -3164.24 | 0.95 | 21.19 | 6.54 | 48.84 |
| Healthcare | 617 | 2.00 | -0.17 | -8.49 | 2.07 | -6.13 | -23.93 | 31.85 | -11.33 | -14.45 | -14.07 | -36805.91 | -4054.41 | 1.05 | 22.33 | 5.93 | 36.37 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
| Ticker | Social Sentiment(1-10) |
|---|---|
| EDIT | 4.00 |
| Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BEAM | Beam Therapeutics Inc. Co | 1.61 | 0.53 | -7.69 | -20.63 | -22.78 | -39.42 | -45.21 | 22 | -21.89 | -38.29 | -9.11 | -27870.79 | -86.89 | 0 | 0 | 16.0483 |
| NTLA | Intellia Therapeutics, In | 1.56 | 3.97 | -2.67 | 2.18 | 10.31 | -36.37 | -43.12 | 39 | -8.64 | -26.94 | -25.79 | -42061.90 | -491.01 | 0 | 0 | 6.34434 |
| TWST | Twist Bioscience Corporat | 1.52 | 3.21 | 0.65 | -18.15 | -27.57 | -54.06 | -63.82 | 26 | -66.91 | -107.92 | -59.93 | -47785.19 | 0.00 | 0 | 0 | 13.5541 |
| CRSP | CRISPR Therapeutics AG | 1.48 | 1.35 | 0.31 | -10.56 | -2.21 | -35.75 | -31.37 | 31 | -17.81 | -27.50 | -18.07 | -15852.76 | -271.66 | 0 | 0 | 8.97713 |
| TDOC | Teladoc Health, Inc. | 1.3 | 5.37 | 2.76 | -12.71 | 6.11 | -12.77 | -61.48 | 30 | -16.62 | -22.27 | -33.67 | -44458.80 | -199.17 | 0 | 150 | 11.8487 |
| IOVA | Iovance Biotherapeutics, | 1.26 | -0.63 | -7.77 | -15.00 | 3.45 | -41.16 | -58.07 | 33 | -19.86 | -57.73 | -45.18 | -31811.50 | -338.25 | 0 | 0 | 9.55114 |
| NVTA | Invitae Corporation | 1.25 | 9.09 | -5.71 | -35.92 | -30.16 | -55.10 | -83.42 | 24 | -40.57 | -63.71 | -81.94 | -50905.73 | 0.00 | 0 | 125 | 11.8279 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.
